Agenus Inc.

NASDAQ:AGEN

Biotechnology

Healthcare
$6.14 -0.17%

-$0.01 today

Market cap
$277.81M
Beta
1.54
P/E (TTM)
1.7
EPS (TTM)
$1.70
52W Low $2.71High $7.34

Volume 0.82M

Average 0.82M

Income Statement

Follow revenue through to earnings.

Revenue

$114.20M

FY 2025 · Annual

+10.4% YoY

Operating Income

-$20.56M

FY 2025 · Annual

Net Income

$115,000.00

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue295.67M98.02M156.31M103.46M114.2M
Cost of Revenue182.08M197.26M237.68M156.01M80.36M
Gross Profit113.59M(99.24M)(81.37M)(52.55M)33.84M
Gross Margin38.4%-101.2%-52.1%-50.8%29.6%
Research & Development178.61M0234.57M155.53M0
Selling, General & Admin76.36M81.01M78.74M71.88M54.39M
Operating Expenses87.84M80.19M78.18M67.92M54.39M
Depreciation & Amortization6.79M6.95M13.59M13.34M10M
EBITDA43.78M(161.85M)(145.92M)(101.3M)62.19M
EBITDA Margin14.8%-165.1%-93.4%-97.9%54.5%
Operating Income25.75M(179.43M)(159.55M)(120.48M)(20.56M)
Operating Margin8.7%-183.0%-102.1%-116.4%-18.0%
Interest Income00000
Interest Expense65.72M61.86M97.93M117.63M55.27M
Other Income / Expenses(54.47M)(51.23M)(97.89M)(111.8M)17.47M
Income Before Tax(28.72M)(230.66M)(257.44M)(232.27M)(3.08M)
Pre-Tax Margin-9.7%-235.3%-164.7%-224.5%-2.7%
Income Tax Expense00000
Net Income(23.93M)(220.07M)(245.76M)(227.21M)115K
Net Margin-8.1%-224.5%-157.2%-219.6%0.1%
EPS (Basic)(2.11)(15.64)(13.75)(10.59)(0.00)
EPS (Diluted)(2.11)(15.64)(13.75)(10.59)(0.00)
Weighted Avg Shares11.45M14.09M17.89M21.47M29.73M
Weighted Avg Shares (Diluted)11.45M14.09M17.89M21.47M29.73M

AGEN Earnings Waterfall · TTM

NASDAQ:AGEN · Revenue to Net Income

Key Ratios

EPS$1.66
Gross Margin47.8%
Net Margin47.0%
P/E Ratio-0.6
P/S Ratio4.0

Analysis

$123.9M of revenue converted into $64.6M of net income for the selected period. Gross margin is 47.8% and net margin is 47.0%, showing how much revenue survives after costs and taxes. EPS is $1.66, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 13, 2026
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026
4Statement of changes in beneficial ownershipOct 2, 2026
4Statement of changes in beneficial ownershipOct 2, 2026

How much revenue does AGEN generate?

Agenus Inc. (AGEN) reported $114.20M of revenue in fiscal 2025.

Is AGEN profitable?

Agenus Inc. (AGEN) reported $115,000.00 of net income, with a net margin of 0.1%.